2 No-Brainer Stocks to Buy Right Now with $1,000

Investors with limited cash can earn two ways and make a fortune with two no-brainer stocks.

| More on:

A small amount of capital is no longer a hindrance to investing in stocks. You don’t need to be flush with cash like the rich to make money in the stock market. With the right investment strategy and choices, $1,000 can go a long way and become a fortune over time.

Healwell AI (TSX:AIDX) and Rogers Sugar (TSX:RSI) are no-brainer stocks to buy right now. Both small-cap stocks are relatively cheap (less than $10 per share combined), but the earning potential is enormous. The healthcare stock is a high-flyer, while the consumer staples stock is a pure-dividend play.

Growth investing

Healwell AI is suitable for growth investors. At only $2.34 per share, the year-to-date gain is an eye-popping 210.7%. A $1,000 investment at year-end 2023 is worth $3,120 today. Market analysts covering AIDX recommend a strong buy rating. Their 12-month average and high price targets are $3.69 and $5, or an upside potential between 57.7% and 113.7%, respectively.

The $370 million healthcare technology company uses artificial intelligence (AI) tools and data science for preventive care and early disease detection. Healwell AI is also a physician-led organization whose mission is to improve healthcare in Canada and save lives.

Healwell AI has yet to report income, although the long-growth runway and nearly $1 billion in M&A opportunities in the clinical and digital space are clear paths to profitability. “We’re incredibly optimistic about our future trajectory, driven by a combination of organic growth and strategic mergers and acquisitions,” said its CEO, Dr. Alexander Dobranowski.

In Q1 2024 (three months ended March 31, 2024), revenue climbed 132% year-over-year to $4.58 million, while net loss improved to $6.3 million compared to $7.44 million in Q1 2023. Dr. Dobranowski believes the strategic alliance with WELL Health Technologies, Canada’s largest outpatient medical clinic owner-operator, is a competitive advantage.

This month alone, Healwell AI entered into agreements to acquire VeroSource Solutions and BioPharma Services. The former will help enterprises adopt AI-powered population health capabilities, while the latter should expand in AI-enable clinical research offerings.

On June 26, 2024, Healwell AI invested US$2 million in xAI, one of the most valuable AI companies globally. The strategic investment is a significant opportunity as it should enhance and accelerate the development of the company’s healthcare-focused data science capabilities.

Dividend investing

Rogers Sugar isn’t a flashy or high-flying stock but a reliable passive income provider. At $5.77 per share, this consumer-defensive stock pays a generous 6.2% dividend. Your $1,000 investment will generate $15.60 every quarter ($62.40 annually).

The $738 million company operates cane sugar refineries and produces sugar and maple products. In the first half of 2024, total revenues and net earnings increased 10.3% and 8% respectively to $589.6 million and $27.8 million versus the same period in 2023. Mike Walton, President and CEO of Rogers and Lantic, said the profitable growth from the business segments reflect strong product demand and improved operations.

Walton expects strong financial results in 2024 due to the ongoing capacity expansion. Rogers Sugar should continue to grow and be an enduring business. 

Profitable options

Healwell AI and Rogers Sugar are profitable investment options for beginners and thrifty investors. With a $1,000 investment, you can be a growth investor, dividend investor, or both.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Dividend Stocks

Canadian dollars are printed
Dividend Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Toronto-Dominion Bank (TSX:TD) stock could do well in the year ahead.

Read more »

monthly desk calendar
Dividend Stocks

Monthly Income: Top Dividend Stocks to Buy in November

Here are two of the best monthly dividend stocks in Canada you can buy in November 2024 and hold for…

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Use Your TFSA to Earn Ultimate Passive Income

If you have a TFSA, then you have the key to creating ultimate passive income. All you need is a…

Read more »

Confused person shrugging
Dividend Stocks

Better Buy: Fortis Stock or Hydro One Stock?

Let's do a compare and contrast of these two top utilities stocks right now, shall we?

Read more »

A close up color image of a small green plant sprouting out of a pile of Canadian dollar coins "loonies."
Dividend Stocks

Boost Your Passive Income: 2 Canadian High-Yielders at a Bargain

Nutrien (TSX:NTR) stock and another play that appear like fantastic dividend bargains in mid-November.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

Hourglass and stock price chart
Dividend Stocks

Goeasy Stock: Is It Heading for a 52-Week High?

Goeasy stock has been edging higher, especially after another record-setting earnings report. So are 52-week highs in sight?

Read more »